"Plain And Obvious" That Innovators' Profits Are Not Available To Generics In ... - Mondaq News Alerts

30-09-2013 Comments (0)


On September 12, 2013, the Ontario Court of Appeal upheld the Superior Court's dismissal of Apotex's claim for disgorgement of Takeda's and Abbott's profits in the context of the Patented Medicines (Notice of Compliance) Regulations (the "NOC ...

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top